|
Market Closed -
Other stock markets
|
After market 03:18:41 pm | |||
| 0.9 EUR | +2.16% |
|
0.901 | +0.11% |
| Apr. 22 | Pharming Group to Buy Back EUR123 Million of Bonds due 2025 | MT |
| Apr. 18 | Pharming Group to Issue EUR100 Million Convertible Bonds, Repurchase EUR125 Million Bonds | MT |
Pharming Group N.V. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was USD 151 million compared to USD 146.1 million a year ago. Net income was USD 28.3 million compared to USD 13.93 million a year ago.
Basic earnings per share from continuing operations was USD 0.043 compared to USD 0.022 a year ago. Diluted earnings per share from continuing operations was USD 0.04 compared to USD 0.018 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -12.71% | 636M | |
| +25.75% | 653B | |
| +27.00% | 556B | |
| -6.55% | 354B | |
| +20.57% | 331B | |
| +2.83% | 296B | |
| +13.09% | 233B | |
| +5.46% | 201B | |
| -9.61% | 193B | |
| -5.90% | 144B |
PHARMING GROUP N.V. 
